X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (473) 473
Publication (14) 14
Patent (7) 7
Conference Proceeding (5) 5
Book Review (4) 4
Book / eBook (2) 2
Book Chapter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (292) 292
female (284) 284
adult (183) 183
index medicus (130) 130
obstetrics & gynecology (105) 105
adolescent (96) 96
middle aged (85) 85
women (78) 78
pregnancy (77) 77
risk factors (68) 68
human papillomavirus (62) 62
cervical cancer (53) 53
infectious diseases (50) 50
health aspects (48) 48
young adult (48) 48
infection (46) 46
papillomavirus infections - prevention & control (46) 46
male (44) 44
cancer (43) 43
oncology (43) 43
chlamydia trachomatis (42) 42
uterine cervical neoplasms - virology (41) 41
vaccination (39) 39
finland (38) 38
finland - epidemiology (38) 38
uterine cervical neoplasms - prevention & control (38) 38
follow-up studies (37) 37
infections (36) 36
papillomavirus infections (36) 36
prevalence (33) 33
vaccines (33) 33
diagnosis (32) 32
risk (32) 32
immunology (31) 31
papillomavirus infections - virology (31) 31
young-women (31) 31
prospective studies (30) 30
prevention (29) 29
medicine, general & internal (28) 28
aged (27) 27
case-control studies (26) 26
chlamydia trachomatis - isolation & purification (26) 26
research (26) 26
retrospective studies (26) 26
abridged index medicus (25) 25
medical and health sciences (25) 25
medicin och hälsovetenskap (25) 25
incidence (24) 24
particle vaccine (24) 24
papillomavirus infections - epidemiology (23) 23
uterine cervical neoplasms - epidemiology (23) 23
analysis (22) 22
cohort studies (22) 22
double-blind method (22) 22
intraepithelial neoplasia (22) 22
sexually transmitted diseases (22) 22
treatment outcome (22) 22
care and treatment (21) 21
cervical intraepithelial neoplasia - virology (21) 21
papillomaviridae - genetics (21) 21
papillomaviridae - immunology (21) 21
papillomaviruses (21) 21
pregnancy outcome (21) 21
animals (20) 20
clinical trials (20) 20
efficacy (20) 20
hpv (20) 20
cervical intraepithelial neoplasia (19) 19
chlamydia infections - epidemiology (19) 19
chlamydia trachomatis - immunology (19) 19
hysterectomy (19) 19
papillomaviridae - isolation & purification (19) 19
womens health (19) 19
antibodies (18) 18
cervical intraepithelial neoplasia - prevention & control (18) 18
chlamydia infections - complications (18) 18
dna, viral - analysis (18) 18
follow-up (18) 18
human papillomavirus 16 - immunology (18) 18
human papillomavirus 18 - immunology (18) 18
infant, newborn (18) 18
pelvic inflammatory disease (18) 18
registries (18) 18
chlamydia infections (17) 17
papillomavirus infections - complications (17) 17
papillomavirus vaccines - administration & dosage (17) 17
risk-factors (17) 17
surgery (17) 17
vaginal smears (17) 17
chlamydia (16) 16
chlamydia infections - diagnosis (16) 16
immunization (16) 16
management (16) 16
menorrhagia (16) 16
microbiology (16) 16
papillomavirus vaccines - therapeutic use (16) 16
united-states (16) 16
biopsy (15) 15
clinical medicine (15) 15
double-blind (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1989, ISBN 0306429659, xiv, 370 p., [2] p. of plates
Book
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Summary Background We evaluated the efficacy of the human papillomavirus HPV-16/18 AS04-adjuvanted vaccine against non-vaccine oncogenic HPV types in the... 
Hematology, Oncology and Palliative Medicine | UNITED-STATES | AGED 16-26 YEARS | ONCOLOGY | PARTICLE VACCINE | NEOPLASIA | MAJOR CAPSID PROTEIN | YOUNG-WOMEN | CANCER | HUMAN-PAPILLOMAVIRUS INFECTION | LESIONS | EPITOPES | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Summary Background Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus... 
Hematology, Oncology and Palliative Medicine | COUNTRIES | ONCOLOGY | PARTICLE VACCINE | ADENOCARCINOMA | HPV VACCINATION | ADOLESCENT WOMEN | FOLLOW-UP | YOUNG-WOMEN | CANCER | CARCINOMA | HUMAN-PAPILLOMAVIRUS INFECTION | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2016, Volume 215, Issue 6, pp. 768.e1 - 768.e8
Journal Article